상세 보기
Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)
- Miller, Richard;
- Wilcox, Ryan;
- Reneau, John;
- Yannakou, Costas;
- Kim, Won Seog;
- 외 9명
Citations
WEB OF SCIENCE
0- 제목
- Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)
- 저자
- Miller, Richard; Wilcox, Ryan; Reneau, John; Yannakou, Costas; Kim, Won Seog; Feldman, Tatyana; Kim, Youn-H; Khodadoust, Michael; Radeski, Dejan; Gasiorowski, Robin; Yoon, Dok Hyun; Song, Yuqin; Hotson, Andrew; Mahabhashyam, Suresh
- 발행일
- 2025-11-03
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- 778 ~ 779